Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
NCT01200732
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER_GOV
Sponsor class
Conditions
Eisenmenger Syndrome
Interventions
DRUG:
Tadalafil, placebo
Sponsor
Govind Ballabh Pant Hospital